Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
67.6M
-
Number of holders
-
116
-
Total 13F shares, excl. options
-
33.4M
-
Shares change
-
+12M
-
Total reported value, excl. options
-
$735M
-
Value change
-
+$323M
-
Put/Call ratio
-
0.8
-
Number of buys
-
82
-
Number of sells
-
-40
-
Price
-
$22.02
Significant Holders of TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) as of Q2 2018
138 filings reported holding TNDM - TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share as of Q2 2018.
TANDEM DIABETES CARE INC - Common Stock, par value $0.001 per share (TNDM) has 116 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 33.4M shares
of 67.6M outstanding shares and own 49.34% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.94M shares), FEDERATED INVESTORS INC /PA/ (2.66M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (2.63M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2.57M shares), FRED ALGER MANAGEMENT INC (1.97M shares), VANGUARD GROUP INC (1.91M shares), First Light Asset Management, LLC (1.9M shares), ORBIMED ADVISORS LLC (1.69M shares), Point72 Asset Management, L.P. (1.24M shares), and STATE STREET CORP (1.21M shares).
This table shows the top 116 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.